litifilimab   Click here for help

GtoPdb Ligand ID: 11122

Synonyms: BIIB-059 | BIIB059
Immunopharmacology Ligand
Compound class: Antibody
Comment: Litifilimab (BIIB059) is a fully humanized IgG1, CLEC4C (blood dendritic cell antigen 2, BDCA2) targeting monoclonal antibody. It is being evaluated for ability to reduce release of disease-driving interferons (principally IFN-α) in SLE/CLE. BIIB059 was developed by Biogen, based on prior evidence of target engagement and SLE-applicable immunomodulatory efficacy of a humanized mAb against BDCA2 named 24F4A [3].
Classification Click here for help
Compound class Antibody
International Nonproprietary Names Click here for help
INN number INN
11943 litifilimab
Synonyms Click here for help
BIIB-059 | BIIB059
Database Links Click here for help
GtoPdb PubChem SID 434122182
Search PubMed clinical trials litifilimab
Search PubMed titles litifilimab
Search PubMed titles/abstracts litifilimab